MEDIFAST (NYSE: MED) Q3 2025 Earnings Disclosure

• Filing Date: November 3, 2025
• Item 2.02: Reports the issuance of the Third Quarter 2025 earnings press release (for period ending September 30, 2025).

Investors must refer to Exhibit 99.1 for the actual financial performance metrics, including revenue, EPS, and any operational updates or guidance provided by the Company.

• This 8-K filing is purely an announcement of the earnings release.

• Management: Report certified by CFO James P. Maloney.

  Medifast (MED) Q3 2025 Investor Summary

Medifast reported significant